Close

Analyst Ratings for Oncolytics Biotech (ONCY) [Neutrals]

ONCY Rating Summary

ONCY Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ONCY
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $5.00 (+385.4%) * Over Last 12-Mos
Rating Score: 7.1 / 10   Percentile Rank: 77%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/9/2015 Piper Sandler N/A Downgrade Neutral
(Overweight)
N/A
(N/A)
0.65
(1.03)
58.46% Details
5/17/2011 Oppenheimer N/A New Coverage Perform
(N/A)
N/A
(N/A)
6.10
(1.03)
-83.11% Details